KSC Equity Snapshot
271980 Weekly Equity Report
Jeil Pharmaceutical Co.,Ltd
What the company does
Jeil Pharmaceutical Co.,Ltd develops and supplies pharmaceutical products primarily in South Korea and internationally. It provides products in the areas of antibiotic, gastrointestinal, cardiovascular, neuropsychiatry, oncology, endocrinology, urology, antiviral, and antihistamine. The company exports its products. Jeil Pharmaceutical Co.,Ltd was founded in 1959 and is headquartered in Seoul, South Korea.
What the weekly tape is saying
271980 closed the latest completed week at 10,230 KRW. The 4-week return is -25.9% and the 12-week return is -28.7%. Trend Signal is inactive, Market Dynamics is -1.51. Setup signature: Risk-first tape with a 13/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 14,224 KRW
- Vs Trend Line
- -28.1%
- Fair Value
- 14,793 KRW
- Vs Fair Value
- -30.8%
- 52W High
- 19,290 KRW
- 52W Low
- 9,500 KRW
- Drawdown
- -47.0%
- Range Position
- 7.5%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 38
- 52W Active Breadth
- 73.1%
- Sector Scope
- KR Healthcare
- Sector Rank
- 24 of 63
- Sector Percentile
- 62.9%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
KR Healthcare
- Tracked Peers
- 63
- 4W Rank
- 60 of 63
- Avg 1W
- -1.0%
- Avg 4W
- -12.7%
- Trend Breadth
- 1.6%
- Positive MD
- 6.3%
KR Drug Manufacturers - Specialty & Generic
- Tracked Peers
- 44
- 4W Rank
- 43 of 44
- Avg 1W
- -1.3%
- Avg 4W
- -12.9%
- Trend Breadth
- 2.3%
- Positive RS
- 0.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -1.51
- 4W MD Change
- -59.7%
- Relative Strength
- -62.41
- 4W RS Change
- -27.7%
- Expectation
- Negative
- Probability
- 43.32%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 98.9K
- 13W Average
- 187.3K
- 52W Average
- 298.0K
- Vs 13W
- 0.5x
- Vs 52W
- 0.3x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 5.1%
- 52W Volatility
- 5.4%
- Upside Weeks
- 28
- Downside Weeks
- 24
- Downside Breadth
- 46.2%
- Avg Gain / Loss
- 3.5% / -4.8%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- KSC
- Country
- KR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- KRW
- Market Cap
- 165.7B
Opportunity signals
- No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 10,230 KRW | 0.5% | 14,224 KRW | 14,793 KRW | -1.51 | -62.41 | 98.9K | Off |
| 5 Jun 2026 | 10,180 KRW | -13.9% | 14,373 KRW | 14,849 KRW | -1.32 | -63.45 | 145.7K | Off |
| 29 May 2026 | 11,830 KRW | -8.3% | 14,485 KRW | 14,911 KRW | -1.17 | -59.84 | 268.4K | Off |
| 22 May 2026 | 12,900 KRW | -6.5% | 14,570 KRW | 14,964 KRW | -1.02 | -53.57 | 289.8K | Off |
| 15 May 2026 | 13,800 KRW | 0.6% | 14,616 KRW | 15,009 KRW | -0.95 | -48.86 | 295.2K | Off |
| 8 May 2026 | 13,720 KRW | -2.0% | 14,629 KRW | 15,043 KRW | -0.94 | -49.92 | 143.3K | Off |
| 1 May 2026 | 14,000 KRW | 0.7% | 14,725 KRW | 15,080 KRW | -1.06 | -42.80 | 120.7K | Off |
| 24 Apr 2026 | 13,900 KRW | -3.1% | 14,763 KRW | 15,111 KRW | -1.23 | -42.92 | 129.2K | Off |
| 17 Apr 2026 | 14,340 KRW | 8.4% | 14,805 KRW | 15,139 KRW | -1.31 | -39.28 | 223.4K | Off |
| 10 Apr 2026 | 13,230 KRW | -1.6% | 14,796 KRW | 15,168 KRW | -1.41 | -41.65 | 198.5K | Off |
| 3 Apr 2026 | 13,440 KRW | -5.5% | 14,814 KRW | 15,216 KRW | -1.21 | -36.43 | 218.1K | Off |
| 27 Mar 2026 | 14,220 KRW | -0.8% | 14,825 KRW | 15,252 KRW | -1.08 | -34.45 | 164.6K | Off |
| 20 Mar 2026 | 14,340 KRW | -4.1% | 14,798 KRW | 15,279 KRW | -0.58 | -38.47 | 139.5K | Off |
| 13 Mar 2026 | 14,950 KRW | 3.5% | 14,767 KRW | 15,304 KRW | -0.48 | -33.01 | 189.4K | On |